Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Puma Biotechnology, Inc. (PBYI) had Free Cash Flow of $17.61M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$52.44M |
|
$5.86M |
|
$12.30M |
|
$40.13M |
|
$45.80M |
|
$6.64M |
|
$-0.47M |
|
$6.17M |
|
$6.17M |
|
$5.86M |
|
$5.86M |
|
$5.86M |
|
$5.86M |
|
$6.64M |
|
$9.40M |
|
49.70M |
|
50.15M |
|
$0.12 |
|
$0.12 |
|
| Balance Sheet Financials | |
$136.58M |
|
$0.39M |
|
$58.34M |
|
$194.92M |
|
$79.10M |
|
$10.87M |
|
$11.10M |
|
$90.20M |
|
$104.72M |
|
$58.46M |
|
$104.72M |
|
49.89M |
|
| Cash Flow Statement Financials | |
$17.69M |
|
$-9.72M |
|
$-22.53M |
|
$71.31M |
|
$56.75M |
|
$-14.56M |
|
$3.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.73 |
|
-- |
|
-- |
|
0.09 |
|
0.43 |
|
76.54% |
|
12.66% |
|
12.66% |
|
-- |
|
11.76% |
|
11.17% |
|
|
Free Cash Flow |
$17.61M |
-- |
|
-- |
|
-- |
|
0.27 |
|
1.43 |
|
2.02 |
|
44.47 |
|
5.59% |
|
10.02% |
|
3.00% |
|
5.07% |
|
$2.10 |
|
$0.35 |
|
$0.35 |
|